INTRODUCTION: Despite advances in breast cancer diagnosis and treatment of the primary tumor, metastatic breast cancer tumors remain largely incurable, and their growth is responsible for the majority of breast cancer-related deaths. There is therefore a critical need to identify ways to reduce metastatic tumor burden and increase breast cancer patient survival. While surgery and pharmacological treatments are the cornerstones of breast cancer intervention, epidemiological data suggests that physical activity can lower the risk of breast cancer development, improve adjuvant treatment tolerance, reduce the risk of disease recurrence and lower breast cancer-related death. METHODS: In this preclinical study, we set out to examine the impact of exercise on metastatic development in triple negative breast cancer (TNBC), using different 4T1 metastasis models, voluntary wheel running and surgical interventions. Tumors were analyzed for hypoxia and immune cell infiltration. RESULTS: Voluntary wheel running was observed to significantly increase metastasis-free survival, doubling the median survival time. However, these improvements were only observed when a boost in physical exercise occurred following surgery. To investigate this, we performed mock surgeries and confirmed surgical stress was needed to enable the positive effects of the boost in exercise on reducing metastatic tumor burden in mice with either spontaneous metastasis or experimentally-induced metastasis. These changes occurred in the absence of alterations in tumor growth, hypoxia and immune cell infiltration. DISCUSSION: Taken together, our results suggest that having a boost of physical activity following surgery may be beneficial to delay breast cancer metastatic development.
Exercise boost after surgery improves survival in model of metastatic breast cancer.
术后加强锻炼可提高转移性乳腺癌模型的生存率
阅读:2
作者:Stagaard Rikke, Jensen Adina, Schauer Tim, Bay Marie Lund, Tavanez Ana Rita, Wielsøe Sabrina, Peletier Merel, Strøbech Jan Erik, Oria Victor Oginga, Zornhagen Kamilla Westarp, Albrechtsen Reidar, Christensen Jesper Frank, Erler Janine Terra
| 期刊: | Frontiers in Immunology | 影响因子: | 5.900 |
| 时间: | 2025 | 起止号: | 2025 Feb 24; 16:1533798 |
| doi: | 10.3389/fimmu.2025.1533798 | 研究方向: | 肿瘤 |
| 疾病类型: | 乳腺癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
